ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Family Health After Predictive Huntington Disease (HD) Testing

This study is currently recruiting participants.
Verified by National Institute of Nursing Research (NINR), January 2004

Sponsored by: National Institute of Nursing Research (NINR)
Information provided by: National Institute of Nursing Research (NINR)
ClinicalTrials.gov Identifier: NCT00075140
  Purpose

The purpose of this study is to identify health management concerns and needs of family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease (HD).


Condition Intervention Phase
Huntington Disease
Gene Transfer: Mutation in the gene
Phase III

Genetics Home Reference related topics:   chorea-acanthocytosis    familial encephalopathy with neuroserpin inclusion bodies    familial paroxysmal nonkinesigenic dyskinesia    Huntington disease    McLeod neuroacanthocytosis syndrome   

MedlinePlus related topics:   Huntington's Disease   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title:   Family Health After Predictive Huntington Disease Testing

Further study details as provided by National Institute of Nursing Research (NINR):

Study Start Date:   September 2001
Estimated Study Completion Date:   June 2005

Detailed Description:

This is a Phase III study. In Phase 1, focus groups consisting of family members of persons with HD Gene mutation will be conducted and data collected to be analyzed through content analysis to identify salient themes and key issues. In Phase 2, a survey instrument will be developed and field-tested in order to describe the health care needs, management strategies, and needs for health and social services of relative/significant others of asymptomatic and symptomatic persons with the mutation in the gene for HD.

In Phase 3, the survey will be distributed to family members of asymptomatic and symptomatic persons with mutation in the gene for HD and frequencies and comparisons of survey responses according to respondent characteristics will be reported.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • Family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00075140

Locations
United States, Iowa
Iowa University College of Nursing     Recruiting
      Iowa City, Iowa, United States, 52242
      Contact: Janet K Williams, PhD     319-335-7046     JANET-WILLIAMS@UIOWA.EDU    

Sponsors and Collaborators
  More Information


Study ID Numbers:   1-R01-NR007970-01
First Received:   January 2, 2004
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00075140
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Nursing Research (NINR):
Patient Care Management  
Family  
Huntington's Disease  

Study placed in the following topic categories:
Ganglion Cysts
Huntington disease
Basal Ganglia Diseases
Central Nervous System Diseases
Brain Diseases
Neurodegenerative Diseases
Dyskinesias
Cognition Disorders
Chorea
Delirium, Dementia, Amnestic, Cognitive Disorders
Heredodegenerative Disorders, Nervous System
Genetic Diseases, Inborn
Mental Disorders
Movement Disorders
Dementia
Huntington Disease
Delirium

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on November 19, 2008




Links to all studies - primarily for crawlers